Jungang Vaccine has newly appeared among the top searched stocks.


As of 11:30 AM on the 26th, Jungang Vaccine is trading at 18,800 KRW, down 2.34% from the previous day. This represents a 20.9% increase compared to March 9. Jungang Vaccine is known as a company that manufactures and sells animal vaccines.

Over the past five days, individual investors have sold a net 25,027 shares, while foreigners and institutions have sold a net 12,975 shares and bought a net 53,319 shares, respectively.


On March 25, Jungang Vaccine became a market issue with the announcement of 'Technology transfer of COVID-19 vaccine adjuvant from Korea Research Institute of Chemical Technology... commercialization...'



※Source: AI Investment Assistant AI Rasero


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing